Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + Very Low-dose Tacrolimus vs EC-MPS + Low-dose Tacrolimus in de Novo Renal Transplant Recipients
NCT02084446Phase 4Completed
- Start
- Dec 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in kidney transplant rejection, cytomegalovirus infection (CMV). Started Dec 2012; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejectioncytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT02084446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084446.